We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSBK icon
2526
Timberland Bancorp
TSBK
$347M
$344K ﹤0.01%
11,577
-20
-0.2% -$560
ITIC
2527
Investors Title Co
ITIC
$543M
$343K ﹤0.01%
2,154
-29
-1% -$4.69K
VWTR
2528
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$343K ﹤0.01%
30,853
+103
+0.3% +$1.1K
RBNC
2529
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$343K ﹤0.01%
15,415
-74
-0.5% -$1.67K
BRK.A icon
2530
Berkshire Hathaway Class A
BRK.A
$1.11T
$340K ﹤0.01%
1
NC icon
2531
NACCO Industries
NC
$357M
$340K ﹤0.01%
7,268
+469
+7% +$24.9K
EIGR
2532
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$340K ﹤0.01%
760
+41
+6% +$14.6K
PKBK icon
2533
Parke Bancorp
PKBK
$402M
$338K ﹤0.01%
14,638
+8
+0.1% +$172
RGCO icon
2534
RGC Resources
RGCO
$224M
$338K ﹤0.01%
11,823
-62
-0.5% -$1.8K
HBMD
2535
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$338K ﹤0.01%
20,014
-106
-0.5% -$1.76K
ALBO
2536
DELISTED
Albireo Pharma Inc
ALBO
$337K ﹤0.01%
13,242
+92
+0.7% +$1.84K
GHM icon
2537
Graham Corp
GHM
$1.24B
$336K ﹤0.01%
15,347
-147
-0.9% -$3.17K
HMTV
2538
DELISTED
Hemisphere Media Group, Inc.
HMTV
$336K ﹤0.01%
22,631
-158
-0.7% -$2.06K
IHC
2539
DELISTED
Independence Holding Company
IHC
$336K ﹤0.01%
7,984
+28
+0.4% +$1.13K
OOMA icon
2540
Ooma
OOMA
$590M
$335K ﹤0.01%
25,359
+114
+0.5% +$1.39K
CNTY icon
2541
Century Casinos
CNTY
$33.8M
$334K ﹤0.01%
42,110
+151
+0.4% +$1.18K
FBIZ icon
2542
First Business Financial Services
FBIZ
$602M
$334K ﹤0.01%
12,693
+37
+0.3% +$917
VLGEA icon
2543
Village Super Market
VLGEA
$642M
$334K ﹤0.01%
14,382
+172
+1% +$4.46K
DNTH icon
2544
Dianthus Therapeutics
DNTH
$6.04B
$333K ﹤0.01%
1,373
+12
+0.9% +$2.24K
EGLE
2545
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$333K ﹤0.01%
10,354
+101
+1% +$3.11K
LCNB icon
2546
LCNB Corp
LCNB
$283M
$331K ﹤0.01%
17,140
+221
+1% +$4.04K
LE icon
2547
Lands' End
LE
$395M
$329K ﹤0.01%
19,573
+39
+0.2% +$510
RUSHB icon
2548
Rush Enterprises Class B
RUSHB
$6.3B
$328K ﹤0.01%
16,171
-97
-0.6% -$1.88K
TIPT icon
2549
Tiptree Inc
TIPT
$662M
$327K ﹤0.01%
40,225
-269
-0.7% -$2.06K
SIGA icon
2550
SIGA Technologies
SIGA
$224M
$326K ﹤0.01%
68,374
+557
+0.8% +$2.84K

Similar funds

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.